Square Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced total revenue was BDT 10,776.321 million compared to BDT 9,852.687 million a year ago. Operating income was BDT 3,412.447 million compared to BDT 3,073.018 million a year ago. Net income was BDT 3,126.368 million compared to BDT 2,855.960 million a year ago. Basic earnings per share was BDT 3.96 compared to BDT 3.62 a year ago. For the half year, total revenue was BDT 21,318.399 million compared to BDT 19,720.637 million a year ago. Operating income was BDT 7,055.373 million compared to BDT 6,490.316 million a year ago. Net income was BDT 6,295.232 million compared to BDT 5,864.392 million a year ago. Basic earnings per share was BDT 7.98 compared to BDT 7.43 a year ago.